Krystal Biotech Files $35M IPO Led By Morrison & Foerster
Krystal Biotech Inc., a gene therapy company developing treatments for rare and severe skin diseases, on Monday filed a $35 million initial public offering to fund its pipeline under guidance from...To view the full article, register now.
Already a subscriber? Click here to view full article